Publicación:
Factores asociados a dislipidemia en pacientes seropositivos para el virus de la inmunodeficiencia humana. Estudio fadevic

dc.contributor.authorVelaides Morelo, Albertospa
dc.contributor.authorDe la Vega Del Risco, Fernandospa
dc.contributor.authorBello Espinosa, Arielspa
dc.date.accessioned2020-12-23 00:00:00
dc.date.available2020-12-23 00:00:00
dc.date.issued2020-12-23
dc.format.mimetypeapplication/pdfspa
dc.identifier.doi10.32997/rcb-2012-3115
dc.identifier.eissn2389-7252
dc.identifier.issn2215-7840
dc.identifier.urihttps://hdl.handle.net/11227/13383
dc.identifier.urlhttps://doi.org/10.32997/rcb-2012-3115
dc.language.isospaspa
dc.publisherUniversidad de Cartagenaspa
dc.relation.bitstreamhttps://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/download/3115/2643
dc.relation.citationeditionNúm. 2 , Año 2012spa
dc.relation.citationendpage274
dc.relation.citationissue2spa
dc.relation.citationstartpage267
dc.relation.citationvolume3spa
dc.relation.ispartofjournalRevista Ciencias Biomédicasspa
dc.relation.referencesGLOBAL HIV/AIDS RESPONSE Epidemic update and health sector. Progress Report 2011. WHO, UNICEF and UNAIDS. http://www.who.int/hiv/data/en/index.html.spa
dc.relation.referencesCuéllar Espitia NC. Instituto Nacional de Salud. Informe de VIH-SIDA Colombia Período XIII de 2010. 2011.spa
dc.relation.referencesFourie CM, van Rooyen JM, Schutte AE. HIV infection and cardiovascular risk in black South Africans[editorial]. Cardiovasc J Afr. 2011;22(3):117-119.spa
dc.relation.referencesGuerra M, Alvarado M, Fonseca V, Valbuena V. Comportamiento del metabolismo lipídico en pacientes con VIH/SIDA de Bogotá. Universitas Scientiarum. 2007;12(2):47-56.spa
dc.relation.referencesLópez P, Caicedo Y, Consuelo L, Cortés C, Valencia A, Ramírez O. et-al. Alteraciones metabólicas con terapia antirretroviral altamente efectiva en niños positivos para VIH, Cali, Colombia. Infectio. 2009;13(4):283-292.spa
dc.relation.referencesBello A, Sotomayor A, Eljaiek R, Díaz C. Grosor de la íntima-media de las carótidas en pacientes con VIH. Acta Médica Colombiana. 2007;32(3):111–115.spa
dc.relation.referencesKhiangte L, Vidyabati RK, Singh MK, Bilasini DS, Rajan ST, Gyaneshwar SW. A study of serum lipid profile in Human Immunodeficiency Virus (HIV) Infected Patients. J Indian Acad Clin Med. 2007;8:307-311.spa
dc.relation.referencesKumar A, Sathian B. Assessment of lipid profile in patients with human immunodeficiency virus (HIV/AIDS) without antiretroviral therapy. Asian Pacific J of Tropical Disease. 2011;1(1):24-27.spa
dc.relation.referencesDepartamento Administrativo Distrital de Salud – DADIS. Perfil epidemiológico de Cartagena de Indias. Año 2010. Programa de vigilancia en salud pública. Cartagena de indias: Alcaldía Mayor de Cartagena; Colombia. 2010.spa
dc.relation.referencesGrupo de Trabajo para el Tratamiento de la Hipertensión Arterial de la Sociedad Europeade Hipertensión (ESH) y de la Sociedad Europea de Cardiología (ESC).Guías de práctica clínica para el tratamiento de la hipertensiónarterial 2007. Rev Esp Cardiol. 2007;60(9):968.e1-94.spa
dc.relation.referencesMolina DI, Merchán A, Jaramillo N, Sánchez G. Dislipidemias.En: Guías de prevención primaria en riesgo cardiovascular: Tópicos Selectos. Revista Colombiana de Cardiología. 2009;16(Supp. 3):89-103.spa
dc.relation.referencesProtocolo de VIH-SIDA. Instituto Nacional de Salud-Ministerio de la Protección Social. Colombia. 2007.spa
dc.relation.referencesOh J, Hegele RA. HIV-associated dyslipidaemia: pathogenesis and treatment. Lancet Infect Dis. 2007;7(12):787-796.spa
dc.relation.referencesMartínez E. Disorders of fat partitioning in treated HIV–infection. Best Pract Res Clin Endocrinol Metab. 2011;25(3):415-27.spa
dc.relation.referencesGiralt M, Domingo P, Villarroya F. Adipose tissue biology and HIV-infection. Best Pract Res Clin Endocrinol Metab. 2011;25(3):487-99.spa
dc.relation.referencesVacarezza M, Vázquez R, Savio E. Alteraciones del metabolismo lipídico en pacientes infectados por VIH. Rev Med Uruguay 2003;19(1):45-52.spa
dc.relation.referencesCeccato MGB, Bonolo PF, Souza Neto AI, Araújo FS, Freitas MIF. Antiretroviral therapy-associated dyslipidemia in patients from a reference center in Brazil. Braz J Med Biol Res. 2011;44(11):1177-1183.spa
dc.relation.referencesLópez P, Caicedo Y, Consuelo L, Cortés C, Valencia A, Ramírez O. et-al. Alteraciones metabólicas con terapia antirretroviral altamente efectiva en niños positivos para VIH. Cali, Colombia. Infectio. 2009;13(4):283-292.spa
dc.relation.referencesRiddler SA, Smit E, Cole SR, Li R, Chmiel JS, Dobs A ET AL. Impact of HIV Infection and HAART on Serum Lipids in Men. JAMA. 2003;289(22):2978-2982.spa
dc.relation.referencesYoung J, Weber R, Rickenbach M, Furrer H, Bernasconi E, Hirschel B, et al. Lipid profiles for antiretroviral-naive patients starting PI- and NNRTI-based therapy in the Swiss HIV Cohort Study. Antivir Ther. 2005;10(5):585-591.spa
dc.relation.referencesSilva EF, Bassichetto KC, Lewi DS. Perfil Lipídico, Fatores de risco cardiovascular e síndrome metabólica em um grupo de pacientes com AIDS. Arq Bras Cardiol. 2009; 93(2):113-118.spa
dc.relation.referencesAnastos K, Lu D, Shi Q, Tien PC, Kaplan RC, Hessol NA, et al. Association of Serum Lipid Levels With HIV Serostatus, Specific Antiretroviral Agents, and Treatment Regimens. J Acquir Immune Defic Syndr. 2007;45(1):34-42.spa
dc.relation.referencesEl-Sadr WM, Mullin CM, Carr A, Gibert C, Rappoport C, Visnegarwala F, et al. Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviral-naïve cohort. HIV Med. 2005;6(2):114-121.spa
dc.relation.referencesFloris-Moore M, Howard AA, Lo Y, Arnsten JH, Santoro N, Schoenbaum EE. Increased serum lipids are associated with higher CD4 lymphocyte count in HIV-infected women. HIV Med. 2006;7(7):421-430.spa
dc.relation.referencesPasupathi P, Bakthavathsalam G, SaravananG, Devaraj A. Changes in CD4+ cell count, lipid profile and liver enzymes in HIV infection and AIDS patients. J Appl Biomed 2008;6:139-145.spa
dc.relation.referencesAdewole OO, Eze S, Betiku Ye, Anteyi E, Wada I, Ajuwon Z, et al. Lipid profile in HIV/AIDS patients in Nigeria. Afr Health Sci. 2010;10(2):144-149.spa
dc.relation.referencesPadmapriyadarsini C, Ramesh Kumar S, Terrin N, Narendran G, Menon PA, Ramachandran G, et al. Dyslipidemia among HIV-infected patients with tuberculosis taking once-daily nonnucleoside reverse-transcriptase inhibitor–based antiretroviral therapy in India. Clin Infect Dis. 2011;52(4):540-546.spa
dc.relation.referencesIffen TS, Efobi H, Usoro CAO, Udonwa NE. Lipid Profile of HIV-Positive Patients Attending University of Calabar Teaching Hospital, Calabar - Nigeria. World Journal of Medical Sciences. 2010;5(4):89-93.spa
dc.relation.referencesObirikorang C, Yeboah F, Quaye L. Serum lipid profiling in highly active antiretroviral therapy-naive HIV positive patients in Ghana; Any Potential Risk? Webmedcentral. 2010; 1(10): WMC001558.spa
dc.relation.referencesAnastos K, Ndamage F, Lu D, Cohen MH, Shi Q, Lazar J et al. Lipoprotein levels and cardiovascular risk in HIVinfected and uninfected rwandan women. AIDS Res Ther. 2010;7:34.spa
dc.relation.referencesStradling C, Chen Y-F, Russell T, Connock M, Thomas GN, et al. The effects of dietary intervention on HIV dyslipidaemia: a systematic review and meta-analysis. PLoS ONE. 2012; 7(6): e38121.spa
dc.relation.referencesLazzaretti RK, Kuhmmer R, Sprinz E, Polanczyk CA, Ribeiro JP. Dietary intervention prevents dyslipidemia associated with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected individuals: a randomized trial. J Am Coll Cardiol. 2012 Mar 13;59(11):979-88.spa
dc.rightsRevista Ciencias Biomédicas - 2020spa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2spa
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/spa
dc.sourcehttps://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/view/3115spa
dc.subjectDislipidemiasspa
dc.subjectInfección por VIHspa
dc.subjectAntirretroviralesspa
dc.subjectFactores de riesgo.spa
dc.titleFactores asociados a dislipidemia en pacientes seropositivos para el virus de la inmunodeficiencia humana. Estudio fadevicspa
dc.title.translatedFactores asociados a dislipidemia en pacientes seropositivos para el virus de la inmunodeficiencia humana. Estudio fadeviceng
dc.typeArtículo de revistaspa
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.type.contentTextspa
dc.type.driverinfo:eu-repo/semantics/articlespa
dc.type.localJournal articleeng
dc.type.versioninfo:eu-repo/semantics/publishedVersionspa
dspace.entity.typePublication

Archivos

Datos de Contacto

Imagen Escudo Universidad de Cartagena

 

 

 

Línea de Atención

Línea Anticorrupción

Síguenos en: